Evidence
Diseases. 2024 Mar 29;12(4):69. doi: 10.3390/diseases12040069.
ABSTRACT
Alcoholic liver disease (ALD) is a major cause of chronic liver disease. This term covers a broad spectrum of liver lesions, from simple steatosis to alcoholic hepatitis and cirrhosis. The pathogenesis of ALD is multifactorial and not fully elucidated due to complex mechanisms related to direct ethanol toxicity with subsequent hepatic and systemic inflammation. The accumulation of pro-inflammatory cytokines and the reduction of anti-inflammatory cytokines promote the development and progression of ALD. To date, there are no targeted therapies to counter the progression of chronic alcohol-related liver disease and prevent acute liver failure. Corticosteroids reduce mortality by acting on the hepatic-systemic inflammation. On the other hand, several studies analyzed the effect of inhibiting pro-inflammatory cytokines and stimulating anti-inflammatory cytokines as potential therapeutic targets in ALD. This narrative review aims to clarify the role of the main cytokines involved in the pathogenesis and treatment of ALD.
PMID:38667527 | DOI:10.3390/diseases12040069
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
AI Q/A [Aikko.com]
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
🌐 90 Days
VR Related Evidence Matrix
- Inflammatory liver diseases and susceptibility to sepsis
- Hepatic extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Interleukins in liver disease treatment
- Therapeutic potential of oleanolic acid in liver diseases
- A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer
- Role of prostaglandin E2 and its receptors in chronic liver disease
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- Role of Angiotensin II in Non-Alcoholic Steatosis Development
- NcRNA Regulated Pyroptosis in Liver Diseases and Traditional Chinese Medicine Intervention: A Narrative Review
- Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
- ERRgamma-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress
- Epidemiological characteristics of inpatients with liver failure at the Beijing You'an Hospital from 2012 to 2021
- Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice
- Aldo-keto reductase family 1 member A1 (AKR1A1) exerts a protective function in alcohol-associated liver disease by reducing 4-HNE accumulation and p53 activation
- Mitochondrial dysfunction: A promising therapeutic target for liver diseases
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Occult liver disease: a multinational perspective
- COVID-19 in Individuals with Chronic Liver Diseases
- Time-Restricted Feeding Ameliorates Methionine-Choline Deficient Diet-Induced Steatohepatitis in Mice
- Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
- Ethanol extracts of Isochrysis zhanjiangensis alleviate acute alcoholic liver injury and modulate intestinal bacteria dysbiosis in mice
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Bacteroides and NAFLD: pathophysiology and therapy
- Exploring the Potential Role of Massa Medicata Fermentata in Alcoholic Liver Injury Disease Based on Network Pharmacology and Animal Experiments
- Spatial genomics: mapping human steatotic liver disease
- Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
- Incretin-based investigational therapies for the treatment of MASLD/MASH
- The double roles of T cell-mediated immune response in the progression of MASLD
- Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis
- Macrophage-specific FGFR1 deletion alleviates high-fat-diet-induced liver inflammation by inhibiting the MAPKs/TNF pathways
- Interaction between fatty acid oxidation and ethanol metabolism in liver
- Role of the angiopoietin-like protein family in the progression of NAFLD
- Chronic liver disease and management with silymarin: an introductory review of a clinical case collection
- Poria cocos polysaccharides improve alcoholic liver disease by interfering with ferroptosis through NRF2 regulation
- Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
- Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
- Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease
- Adipose-derived extracellular vesicles - a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome
- Glucosamine attenuates alcohol-induced acute liver injury via inhibiting oxidative stress and inflammation
- Bacillus coagulans regulates gut microbiota and ameliorates the alcoholic-associated liver disease in mice
- Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort study
- Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis
- Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
- Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study
- Cyanidin-3-O-Glucoside Alleviates Alcoholic Liver Injury via Modulating Gut Microbiota and Metabolites in Mice
- Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Mannose Supplementation Curbs Liver Steatosis and Fibrosis in Murine MASH by Inhibiting Fructose Metabolism
- Costunolide attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease
- Alcohol-Related liver disease: A global perspective
- Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
- Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review)
- Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma
- Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease
- Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease
- Atorvastatin on Treatment of Nonalcoholic Fatty Liver Disease Patients
- The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review
- Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
- Yanggan Jiangmei Formula alleviates hepatic inflammation and lipid accumulation in non-alcoholic steatohepatitis by inhibiting the NF-kappaB/NLRP3 signaling pathway
Evidence Blueprint
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
Save Evidence Blueprint
Save as PDF
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
🌐 365 Days
VR Related Evidence Matrix
- Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation
- Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
- Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease
- Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease
- Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease
- Alcohol and the mechanisms of liver disease
- Inflammatory liver diseases and susceptibility to sepsis
- Glabridin Ameliorates Alcohol-Caused Liver Damage by Reducing Oxidative Stress and Inflammation via p38 MAPK/Nrf2/NF-κB Pathway
- Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases
- Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease
- Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease
- Hepatic extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
- Interleukins in liver disease treatment
- NLRP3: a new therapeutic target in alcoholic liver disease
- Progress in the mechanism of autophagy and traditional Chinese medicine herb involved in alcohol-related liver disease
- Therapeutic potential of oleanolic acid in liver diseases
- Management of alcoholic hepatitis: A clinical perspective
- Hydrogen gas ameliorates acute alcoholic liver injury via anti-inflammatory and antioxidant effects and regulation of intestinal microbiota
- Insights of mitochondrial involvement in alcoholic fatty liver disease
- From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
- A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer
- Statins are associated with a decreased risk of severe liver disease in individuals with non-cirrhotic chronic liver disease
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- Role of prostaglandin E2 and its receptors in chronic liver disease
- Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- 1H NMR Serum Metabolomic Change of Trimethylamine N-oxide (TMAO) Is Associated with Alcoholic Liver Disease Progression
- Current and future treatment for alcoholic-related liver diseases
- Integrated Multidisciplinary Management of Alcohol-associated Liver Disease
- Liver-adipose tissue crosstalk in alcohol-associated liver disease: The role of mTOR
- Role of Angiotensin II in Non-Alcoholic Steatosis Development
- NcRNA Regulated Pyroptosis in Liver Diseases and Traditional Chinese Medicine Intervention: A Narrative Review
- ZONAL EXPRESSION OF STARD1 AND OXIDATIVE STRESS IN ALCOHOLIC-RELATED LIVER DISEASE
- Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
- Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease
- Protection of Inonotus hispidus (Bull.) P. Karst. against Chronic Alcohol-Induced Liver Injury in Mice via Its Relieving Inflammation Response
- ERRgamma-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress
- Corrected and republished from: Metabolic associated liver disease
- Epidemiological characteristics of inpatients with liver failure at the Beijing You'an Hospital from 2012 to 2021
- The role of Sirtuin 2 in liver - An extensive and complex biological process
- Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice
- Aldo-keto reductase family 1 member A1 (AKR1A1) exerts a protective function in alcohol-associated liver disease by reducing 4-HNE accumulation and p53 activation
- Mitochondrial dysfunction: A promising therapeutic target for liver diseases
- A Patient with Alcoholic Liver Disease Reports for Treatment of Dentoalveolar Abscess in Relation to Maxillary Left Molar
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Occult liver disease: a multinational perspective
- Porphyromonas gingivalis exacerbates alcoholic liver disease by altering gut microbiota composition and host immune response in mice
- The Monoacylglycerol Lipase Inhibitor ABX-1431 Does Not Improve Alcoholic Liver Disease
- Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation
- The role of neutrophils in alcohol-related hepatitis
- COVID-19 in Individuals with Chronic Liver Diseases
- Time-Restricted Feeding Ameliorates Methionine-Choline Deficient Diet-Induced Steatohepatitis in Mice
- Drinking and laboratory biomarkers, and nutritional status characterize the clinical presentation of early-stage alcohol-associated liver disease
- Recent insight into the role of macrophage in alcohol-associated liver disease: a mini-review
- Direct/Conjugated Hyperbilirubinemia as an Uncommon Presentation of Acute Alcoholic Hepatitis: A Case Report
- Macrophage heterogeneity role in NAFLD and NASH disease progression
- Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside
- Dissecting the potential role of ferroptosis in liver diseases: an updated review
- Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
- Ethanol extracts of Isochrysis zhanjiangensis alleviate acute alcoholic liver injury and modulate intestinal bacteria dysbiosis in mice
- FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease